Summary
Mucopolysaccharidosis IVA is an autosomal recessive disease caused by the deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS). Mutation screening of the GALNS gene was performed for seven MPS IVA patients with attenuated phenotypes from three unrelated families. Four of 5 missense mutations identified in this study (p.F167V, p.R253W, p.R380S, p.P484S) and two reported (p.F97V, p.N204K), associated with attenuated phenotypes, were characterized using in vitro stable expression experiments, enzyme kinetic study, protein processing and structural analysis. The stably expressed mutant enzymes defining the attenuated phenotype exhibited a considerable residual activity (1.2–36.7% of the wild-type GALNS activity) except for p.R380S. Enzyme kinetic studies showed that p.F97V, p.F167V and p.N204K have lower affinity to the substrate compared with other mutants. The p.F97V enzyme was the most thermolabile at 55°C. Immunoblot analyses indicated a rapid degradation and/or an insufficiency in processing in the mutant proteins. Tertiary structure analysis revealed that although there was a tendency for ‘attenuated’ mutant residues to be located on the surface of GALNS, they have a different effect on the protein including modification of the hydrophobic core and salt-bridge formation and different potential energy. This study demonstrates that ‘attenuated’ mutant enzymes are heterogeneous in molecular phenotypes, including biochemical properties and tertiary structure.
Similar content being viewed by others
References
Baker E, Guo XH, Orsborn AM, et al (1993) The morquio A syndrome (mucopolysaccharidosis IVA) gene maps to 16q24.3. Am J Hum Genet 52: 96–98.
Beck M, Glossl J, Grubisic A, Spranger J (1986) Heterogeneity of Morquio disease. Clin Genet 29: 325–331.
Bond CS, Clements PR, Ashby SJ, et al (1997) Structure of a human lysosomal sulfatase. Structure 5(2): 277–289.
Bunge S, Kleijer WJ, Tylki-Szymanska A, et al (1997) Identification of 31 novel mutations in the N-acetylgalactosamine-6-sulfatase gene reveals excessive allelic heterogeneity among patients with Morquio A syndrome. Hum Mutat 10: 223–232.
Cole DE, Fukuda S, Gordon BA, et al (1996) Heteroallelic missense mutations of the galactosamine-6-sulfate sulfatase (GALNS) gene in a mild form of Morquio disease (MPS IVA). Am J Med Genet 63: 558–565.
Fan JQ, Ishii S (2003) Cell-based screening of active-site specific chaperone for the treatment of Fabry disease. Methods Enzymol 363: 412–420.
Fukuda S, Tomatsu S, Masue M, et al (1992) Mucopolysaccharidosis type IVA. N-acetylgalactosamine-6-sulfate sulfatase exonic point mutations in classical Morquio and mild cases. J Clin Invest 90: 1049–1053.
Fukuda S, Tomatsu S, Cooper A, et al (1996) Mucopolysaccharidosis IVA (Morquio A): three novel small deletions in the N-acetylgalactosamine-6-sulfate sulfatase gene. Hum Mutat 8: 187–190.
Fukuda S, Yamada N, Tomatsu S, et al (1997) Mucopolysaccharidosis IVA: a novel splice acceptor site mutation in intron 4 of the N-acetylgalactosamine-6-sulfate sulfatase gene in an Afghanistan girl with classical Morquio disease. Jpn J Hum Genet 42: 317–322.
Grantham R (1974) Amino acid difference formula to help explain protein evolution. Science 185: 862–864.
Kato Z, Fukuda S, Tomatsu S, et al (1997) A novel common missense mutation G301C in the N-acetylgalactosamine-6-sulfate sulfatase gene in mucopolysaccharidosis IVA. Hum Genet 101: 97–101.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1): 265–275.
Lukatela G, Krauss N, Theis K, et al (1998) Crystal structure of human arylsulfatase A: the aldehyde function and the metal ion at the active site suggest a novel mechanism for sulfate ester hydrolysis. Biochemistry 37(11): 3654–3664.
Masue M, Sukegawa K, Orii T, Hashimoto T (1991) N-Acetylgalactosamine-6-sulfate sulfatase in human placenta: purification and characteristics. J Biochem 110: 965–970.
Masuno M, Tomatsu S, Nakashima Y, et al (1993) Mucopolysaccharidosis IV A: assignment of the human N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene to chromosome 16q24. Genomics 16: 777–778.
Montaño AM, Kaitila I, Sukegawa K, et al (2003) Mucopolysaccharidosis IVA: characterization of a common mutation found in Finnish patients with attenuated phenotype. Hum Genet 113: 162–169.
Montaño AM, Tomatsu S, Gottesman GS, Smith M, Orii T (2007) International Morquio A Registry: clinical manifestation and natural course of Morquio A disease. J Inherit Metab Dis 30: 165–174.
Nakashima Y, Tomatsu S, Hori T, et al (1994) Mucopolysaccharidosis IV A: molecular cloning of the human N-acetylgalactosamine-6-sulfatase gene (GALNS) and analysis of the 5’ flanking region. Genomics 20: 99–104.
Nelson J, Kinirons M (1988) Clinical findings in 12 patients with MPS IV A (Morquio’s disease). Further evidence for heterogeneity. Part II: Dental findings. Clin Genet 33: 121–125.
Nelson J, Thomas PS (1988) Clinical findings in 12 patients with MPS IV A (Morquio’s disease). Further evidence for heterogeneity. Part III: Odontoid dysplasia. Clin Genet 33: 126–130.
Nelson J, Broadhead D, Mossman J (1988) Clinical findings in 12 patients with MPS IV A (Morquio’s disease). Further evidence for heterogeneity. Part I: Clinical and biochemical findings. Clin Genet 33: 111–120.
Niwa H, Yamamura K, Miyazaki J (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108: 193–199.
Ogawa T, Tomatsu S, Fukuda S, et al (1995) Mucopolysaccharidosis IVA: screening and identification of mutations of the N-acetylgalactosamine-6-sulfate sulfatase gene. Hum Mol Genet 4(3): 341–349.
Sukegawa K, Orii T (1982) Residual activity in fibroblasts from two brothers with the late-onset form of N-acetylgalactosamine-6-sulphate sulphatase deficiency. J Inherit Metab Dis 5: 231–232.
Sukegawa K, Nakamura H, Kato Z, et al (2000) Biochemical and structural analysis of missense mutations in N-acetylgalactosamine-6-sulfate sulfatase causing mucopolysaccharidosis IVA phenotypes. Hum Mol Genet 9: 1283–1290.
Sukegawa-Hayasaka K, Kato Z, et al (2006) Effect of Hunter disease (mucopolysaccharidosis type II) mutations on molecular phenotypes of iduronate-2-sulfatase: enzymatic activity, protein processing and structural analysis. J Inherit Metab Dis 29: 755–761.
Tomatsu S, Fukuda S, Masue M, et al (1991) Morquio disease: isolation, characterization and expression of full-length cDNA for human N-acetylgalactosamine-6-sulfate sulfatase. Biochem Biophys Res Commun 181: 677–683.
Tomatsu S, Fukuda S, Cooper A, et al (1995a) Mucopolysaccharidosis type IVA: identification of six novel mutations among non-Japanese patients. Hum Mol Genet 4: 741–743.
Tomatsu S, Fukuda S, Cooper A, et al (1995b) Mucopolysaccharidosis IVA: identification of a common missense mutation I113F in the N-acetylgalactosamine-6-sulfate sulfatase gene. Am J Hum Genet 57: 556–563.
Tomatsu S, Fukuda S, Yamagishi A, et al (1996) Mucopolysaccharidosis IVA: four new exonic mutations in patients with N-acetylgalactosamine-6-sulfate sulfatase deficiency. Am J Hum Genet 58: 950–962.
Tomatsu S, Fukuda S, Cooper A, et al (1997) Fourteen novel mucopolysaccharidosis IVA producing mutations in GALNS gene. Hum Mutat 10: 368–375.
Tomatsu S, Dieter T, Schwartz IV, et al (2004a) Identification of a common mutation in mucopolysaccharidosis IVA: correlation among genotype, phenotype, and keratan sulfate. J Hum Genet 49: 490–494.
Tomatsu S, Filocamo M, Orii KO, et al (2004b) Mucopolysaccharidosis IVA (Morquio A): identification of novel common mutations in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene in Italian patients. Hum Mutat 24: 187–188.
Tomatsu S, Nishioka T, Montaño AM, et al (2004c) Mucopolysaccharidosis IVA: identification of mutations and methylation study in GALNS gene. J Med Genet 41: e98.
Tomatsu S, Montaño AM, Nishioka T, et al (2005) Mutation and polymorphism spectrum of the GALNS gene in mucopolysaccharidosis IVA (Morquio A). Hum Mutat 26: 500–512.
Tomatsu S, Montaño AM, Lopez P, et al (2006) Determinant factors of spectrum of missense variants in mucopolysaccharidosis IVA gene. Mol Genet Metab 89: 139–149.
Yamada N, Fukuda S, Tomatsu S, et al (1998) Molecular heterogeneity in mucopolysaccharidosis IVA in Australia and Northern Ireland: nine novel mutations including T312S, a common allele that confers a mild phenotype. Hum Mutat 11: 202–208.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Ed Wraith
Competing interests: None declared
References to electronic databases: MPS IVA: OMIM #253000. GALNS: EC 3.1.6.4.
Rights and permissions
About this article
Cite this article
Montaño, A.M., Sukegawa, K., Kato, Z. et al. Effect of ‘attenuated’ mutations in mucopolysaccharidosis IVA on molecular phenotypes of N-acetylgalactosamine-6-sulfate sulfatase. J Inherit Metab Dis 30, 758–767 (2007). https://doi.org/10.1007/s10545-007-0702-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-007-0702-z